Building on GE HealthCare’s more than 50 years of clinical excellence in patient monitoring, Carevance is an advanced, reliable monitoring solution that leverages proprietary algorithms and proven technologies to help hospitals and physicians deliver consistent, high-quality care.
GE HealthCare announced that it has received CE Mark approval for its Carevance patient monitor, giving more customers in Europe access to affordable and reliable care. Building on GE HealthCare’s clinical excellence, Carevance provides a clinically reliable and cost-effective solution with validated parameters and an intuitive, efficient workflow that helps care teams focus on their patients. Today’s hospitals face new challenges, from staffing shortages and increasing patient complexity to financial pressures and evolving technological demands. Carevance is designed to help hospitals and clinicians deliver consistent, high-quality patient monitoring through proven clinical algorithms and scalable parameters, enabling flexible deployment across a variety of care settings.
Health Technology Insights: Cohere Health Launches AI Prior Authorization Tool
Carevance introduces the new Cardiac Output Insights feature, which combines a clinically validated algorithm with a visual decision support tool, enabling physicians to extend advanced hemodynamic monitoring to more patients without the need for additional hardware, invasive catheters, or high costs. This feature provides physicians with the flexibility to easily visualize factors that influence hemodynamic status and delivers clinical insights based on the latest guidelines. With a single click, Carevance users can activate the feature to access a real-time graphical representation of patient data, helping them monitor and understand changes in hemodynamic stability during and after surgery.
Health Technology Insights: Dermatology of Miami Adds Dr. George Glinos to Team
“Although current guidelines recommend cardiac output monitoring during high-risk surgeries, access to this type of monitoring remains limited,” said Dr. Frédéric Michard, MD, PhD. “There is a need to make cardiac output monitoring more accessible so that physicians have the information they need to understand the underlying mechanisms of hemodynamic instability and make informed therapeutic decisions.”
Carevance leverages GE HealthCare’s proprietary algorithms and proven technologies to deliver accurate and consistent measurements across all acute care settings. With clinically validated accuracy across all key vital signs—including oxygen saturation, electrocardiogram (ECG), and respiratory rate—Carevance ensures clinicians can trust the data they receive and contributes to better treatment decisions. Designed with operational efficiency in mind, Carevance includes technologies such as the EK-Pro algorithm, which can help reduce false ECG alarms by up to 92%, allowing caregivers to better focus on their patients.
“As healthcare systems face new demands and challenges, the need for accessible, affordable, and trustworthy solutions is critical,” said Neal Sandy, General Manager, Monitoring Solutions, GE HealthCare. “Carevance combines reliable clinical parameters, proven acute care workflows, and the ability to continuously monitor cardiac output—providing clinicians with real-time insights to support confident decision-making across all acute care settings. The launch of Carevance further strengthens GE HealthCare’s portfolio of monitoring solutions and underscores our commitment to eliminating the trade-off between clinical excellence and affordability.”
Carevance expands GE HealthCare’s modular portfolio of monitoring solutions, built on the promise of a unified monitoring solution for every patient and every changing need. Along with the best-in-class flexibility of Carescape, Carevance expands access to advanced, scalable monitoring—providing clinical excellence and adaptability for diverse hospital settings. GE HealthCare’s technology has received global design recognition, receiving the 2022 iF Design Gold Award for Product Design for Portrait Mobile and the 2023 iF Design Award for Carescape Canvas.
Health Technology Insights: Town Hall Ventures Closes $440Million Fund to Boost AI Healthcare Access
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – businesswire
